Gara Jalqabaatti › Kansara Qara'a Non-Small Cell › Washington › Tacoma
Qorannoo klinikaalii Kansara Qara'a Non-Small Cell Tacoma, WA keessatti
Qorannoo 20 Kansara Qara'a Non-Small Cell f Tacoma fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Assess Adverse Events and How Intravenously (IV) Infused Telisotuzumab Vedotin (ABBV-399) Moves Through the Body as a Monotherapy in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Northwest Medical Specialties Tacoma /ID# 270534, Tacoma
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 1/2
- Northwest Medical Specialties Tacoma /ID# 270469, Tacoma
- Vista Oncology - East Olympia /ID# 275438, Olympia · Miili 26 fagaatti
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Namoota walitti qabaa jiraSadarkaa 3
- Northwest Medical Specialties - Tacoma, Tacoma
- Northwest Medical Specialties - Gig Harbor, Gig Harbor · Miili 8 fagaatti
- Northwest Medical Specialties - Puyallup Medical Oncology, Puyallup · Miili 8 fagaatti
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Network Vista Oncology Division-West office, Olympia · Miili 26 fagaatti
- American Oncology Network Vista Oncology Division-East office, Olympia · Miili 26 fagaatti
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Namoota walitti qabaa jiraSadarkaa 3
- Vista Oncology Inc PS, Olympia · Miili 26 fagaatti
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2
- Vista Oncology, Olympia · Miili 26 fagaatti
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Namoota walitti qabaa jiraSadarkaa 3
- American Oncology Network Vista Oncology Division-West office, Olympia · Miili 26 fagaatti
- American Oncology Network Vista Oncology Division-East office, Olympia · Miili 26 fagaatti
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Namoota walitti qabaa jiraSadarkaa 1/2
- Northwest Medical Specialties, Tacoma
Pan-tumor MRD Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Northwest Medical Specialties (NWMS), Tacoma
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Tacoma
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
Namoota walitti qabaa jiraSadarkaa 3
- Local Institution - 0499, Lacey · Miili 23 fagaatti
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Tacoma
- Research Site, Olympia · Miili 26 fagaatti
Study to Evaluate Adverse Events, Optimal Dose, and Change in Disease Activity, With Livmoniplimab in Combination With Budigalimab Plus Chemotherapy Versus IV Infused Pembrolizumab Plus Chemotherapy in Adult Participants With Untreated Metastatic Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
Namoota walitti qabaa jiraSadarkaa 2/3
- Vista Oncology - East Olympia /ID# 262303, Olympia · Miili 26 fagaatti
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Tacoma
Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Northwest Medical Specialties, Tacoma
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Tacoma
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Exigent Research, LLC, Tacoma
- Northwest Medical Specialities, PLLC, Tacoma
- Northwest Medical Specialities. PLLC, Gig Harbor · Miili 8 fagaatti
- fi 3 dabalataa
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Namoota walitti qabaa jiraSadarkaa 3
- MultiCare Institute for Research & Innovation, Tacoma
- MultiCare Regional Cancer Center, Gig Harbor · Miili 8 fagaatti
- MultiCare Regional Cancer Center, Puyallup · Miili 8 fagaatti
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 2
- USA09-0, Puyallup · Miili 8 fagaatti
BostonGene and Exigent Genomic INsight Study
Namoota walitti qabaa jiraQorannoo ilaalaa
- Northwest Medical Specialities, Puyallup · Miili 8 fagaatti
Qorannoo Kansara Qara'a Non-Small Cell magaalota biroo keessatti
- Houston, TXQorannoo 145
- New York City, NYQorannoo 121
- Arlington, VAQorannoo 104
- Nashville, TNQorannoo 97
- Boston, MAQorannoo 90
- Los Angeles, CAQorannoo 87
- St. Louis, MOQorannoo 73
- Chicago, ILQorannoo 61
- Baltimore, MDQorannoo 60
- San Antonio, TXQorannoo 59
- Columbus, OHQorannoo 57
- Washington, DCQorannoo 55
Qorannoo biroo Tacoma keessatti
- Saree OljooQorannoo 18
- Colitis UlcerativeQorannoo 15
- Myeloma Baay’eeQorannoo 13
- Kansarii ProstateQorannoo 11
- Dhukkuba KrooniiQorannoo 11
- Kansarii ColorectalQorannoo 9
- Kansara MetastatikiiQorannoo 9
- MelanomaQorannoo 7
- Kansarii OvariiQorannoo 7
- Kanisa HarkaaQorannoo 6
- Kansaara EsophagusQorannoo 6
- Saree (Gosoota Hunda)Qorannoo 6
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.